Literature DB >> 17846904

Reduced alveolar macrophage migration induced by acute ambient particle (PM10) exposure.

Peter G Barlow1, David M Brown, Ken Donaldson, Janis MacCallum, Vicki Stone.   

Abstract

Increased levels of particulate air pollution (PM10) have been implicated as a causal agent in pulmonary disease exacerbation and increased deaths from respiratory and cardiovascular disorders. The exact mechanism by which PM10 drives toxicity in the lung is still unknown, but studies have focused on inhibition of macrophage function and impaired alveolar clearance mechanisms. To assess the effects of PM10 on pulmonary macrophage clearance mechanisms ex vivo, Wistar rats were instilled with 125 or 250 microg of PM10 collected from the North Kensington, London. Control rats were instilled with sterile saline. The rats were sacrificed after 18 h and a bronchoalveolar lavage (BAL) was performed. Macrophages isolated from the BAL fluid were assessed for ability to migrate towards a positive chemoattractant (ZAS) ex vivo and to perform phagocytosis. Macrophages isolated from the PM10-exposed rats showed inhibition of potential to migrate. Macrophage phagocytic ability ex vivo was also significantly reduced by the presence of PM10 inside the cells. This study indicates that acute PM10 exposure diminishes macrophage motility and phagocytosis in a manner that could prove deleterious to particle clearance from the alveolar region of the lung. Decreased particle clearance promotes inflammation, and hence, warrants further investigation in relation to the effects of chronic PM10 exposure on macrophage clearance mechanisms and establishing the mechanisms behind decreased macrophage migration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846904     DOI: 10.1007/s10565-007-9033-y

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  12 in total

Review 1.  Macrophage phagocytosis: effects of environmental pollutants, alcohol, cigarette smoke, and other external factors.

Authors:  John Karavitis; Elizabeth J Kovacs
Journal:  J Leukoc Biol       Date:  2011-08-30       Impact factor: 4.962

Review 2.  Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?

Authors:  Peter Hoet; Barbara Legiest; Jorina Geys; Benoit Nemery
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Leveraging the Comparative Toxicogenomics Database to Fill in Knowledge Gaps for Environmental Health: A Test Case for Air Pollution-induced Cardiovascular Disease.

Authors:  Allan Peter Davis; Thomas C Wiegers; Cynthia J Grondin; Robin J Johnson; Daniela Sciaky; Jolene Wiegers; Carolyn J Mattingly
Journal:  Toxicol Sci       Date:  2020-10-01       Impact factor: 4.849

Review 4.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

Review 5.  Particulate matter air pollution and respiratory impact on humans and animals.

Authors:  Caterina Losacco; Antonella Perillo
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-04       Impact factor: 4.223

6.  Chronic Household Air Pollution Exposure Is Associated with Impaired Alveolar Macrophage Function in Malawian Non-Smokers.

Authors:  Jamie Rylance; Chikondi Chimpini; Sean Semple; David G Russell; Malcolm J Jackson; Robert S Heyderman; Stephen B Gordon
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

7.  Functional consequences for primary human alveolar macrophages following treatment with long, but not short, multiwalled carbon nanotubes.

Authors:  Sinbad Sweeney; Davide Grandolfo; Pakatip Ruenraroengsak; Teresa D Tetley
Journal:  Int J Nanomedicine       Date:  2015-04-23

8.  Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation.

Authors:  Nicholas J Kenyon; Jennifer M Bratt; Joyce Lee; Juntao Luo; Lisa M Franzi; Amir A Zeki; Kit S Lam
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

9.  Lysosomal Disorders Drive Susceptibility to Tuberculosis by Compromising Macrophage Migration.

Authors:  Russell D Berg; Steven Levitte; Mary P O'Sullivan; Seónadh M O'Leary; C J Cambier; James Cameron; Kevin K Takaki; Cecilia B Moens; David M Tobin; Joseph Keane; Lalita Ramakrishnan
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

Review 10.  Recent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studies.

Authors:  Abderrahim Nemmar; Jørn A Holme; Irma Rosas; Per E Schwarze; Ernesto Alfaro-Moreno
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.